Advanced, higher priced biologics push the US OrthoBio Market higherBased on Q418/FY18 SmartTRAK Financial Dashboard reporting:
- US Bone Replacement grew +2.3% YoY, with FY18 revenues up +2.7%.
- US Cartilage Replacement increased 55.7% YoY, with FY18 revenues up 34.7%.
- US Soft Tissue Augmentation grew 2.3%, with FY18 revenues growing 9.2%.
- US Tendon Allografts posted an 8.4% YoY increase, with FY18 revenues up +3.9% YoY
- US Meniscal Implant market, with robust growth, was up 15.6% YoY for Q418 with FY18 revenues increasing by 3.0%.
Among the many topics covered in the Q418/FY18 OrthoBio Market Recap are:
- OrthoBio Market Overview
- Slower Growth for US Bone Replacement Market
- Impressive Growth for US Cartilage Replacement
- Solid Performance for US Soft Tissue Replacement
- Unprecedented Q418 for US Meniscal Implant Market
- Q418 Regulatory Highlights